PALO ALTO, Calif.--(BUSINESS WIRE)--Hercules Technology Growth Capital, Inc. (NASDAQ: HTGC), a leading specialty finance company providing growth capital in the form of venture debt and equity to venture capital and private equity backed technology and life science companies at all stages of development, today announced that on August 22, 2007, it provided $1.5 million of equity to Inotek Pharmaceuticals Corporation, a drug development company focused on oncology, cardiovascular and inflammatory diseases. In total, Inotek raised $19.3 million in the Series C round.
